Inventor · disambiguated record
Mikayel Mkrtichyan
Also filed as: MKRTICHYAN MIKAYEL
17 granted patents·20 pending applications·64 citations·filing 2013–2025
93Inventor score
Files withUNIV RES INST INC AUGUSTA18GEORGIAMUNE INC6GEORGIAMUNE LLC4PDS BIOTECHNOLOGY CORP4AUGUSTA UNIV RES INST INC2
Top patents by PatentIndex Score
37 records- 0194US10980878B2Methods and compositions for modulating Akt3 activityUNIV RES INST INC AUGUSTA·Filed 2020·Granted Apr 20, 2021·3 cites·11 claims
- 0294US10828364B2Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositionsPDS BIOTECHNOLOGY CORP·Filed 2019·Granted Nov 10, 2020·8 cites·19 claims
- 0394US10588966B2Methods and compositions for inhibiting Akt3UNIV RES INST INC AUGUSTA·Filed 2019·Granted Mar 17, 2020·5 cites·14 claims
- 0493US11780921B2Antibodies to programmed cell death protein 1UNIV RES INST INC AUGUSTA·Filed 2021·Granted Oct 10, 2023·2 cites·15 claims
- 0593US10342868B2Methods and compositions for inhibiting Akt3UNIV RES INST INC AUGUSTA·Filed 2017·Granted Jul 9, 2019·6 cites·12 claims
- 0692US11021540B2Antibodies to programmed cell death protein 1UNIV RES INST INC AUGUSTA·Filed 2018·Granted Jun 1, 2021·4 cites·12 claims
- 0792US10525049B2Specific Akt3 inhibitor and uses thereofUNIV RES INST INC AUGUSTA·Filed 2019·Granted Jan 7, 2020·5 cites·8 claims
- 0892US10292978B2Specific Akt3 inhibitor and uses thereofUNIV RES INST INC AUGUSTA·Filed 2017·Granted May 21, 2019·6 cites·9 claims
- 0991US12201685B2Methods of modulating immune responses with cationic lipid vaccine compositionsPDS BIOTECHNOLOGY CORP·Filed 2020·Granted Jan 21, 2025·2 cites·18 claims
- 1090US10159731B2Methods and compositions for inhibiting Akt3UNIV RES INST INC AUGUSTA·Filed 2018·Granted Dec 25, 2018·6 cites·2 claims
- 1189US11013735B2Specific Akt3 inhibitor and uses thereofUNIV RES INST INC AUGUSTA·Filed 2019·Granted May 25, 2021·2 cites·7 claims
- 1288US10286064B2Cationic lipid vaccine compositions and methods of usePDS BIOTECHNOLOGY CORP·Filed 2013·Granted May 14, 2019·9 cites·3 claims
- 1388US9707278B2Methods of modulating immune responses by modifying Akt3 bioactivityAUGUSTA UNIV RES INST INC·Filed 2015·Granted Jul 18, 2017·4 cites·6 claims
- 1484US12209127B2Antibodies to programmed cell death protein 1UNIV RES INST INC AUGUSTA·Filed 2023·Granted Jan 28, 2025·0 cites·21 claims
- 1583US11291719B2Methods and compositions for modulating Akt3UNIV RES INST INC AUGUSTA·Filed 2020·Granted Apr 5, 2022·1 cites·16 claims
- 1682US11957673B2Specific AKT3 activator and uses thereofUNIV RES INST INC AUGUSTA·Filed 2018·Granted Apr 16, 2024·1 cites·29 claims
- 1779US2024316190A1Compositions and methods for selectively modulating tregsUNIV RES INST INC AUGUSTA·Filed 2023·Application pending·0 cites
- 1875US12168687B2Antibodies to programmed cell death protein 1 that are PD-1 agonistsGEORGIAMUNE INC·Filed 2024·Granted Dec 17, 2024·0 cites·30 claims
- 1975US2025009735A1Specific akt3 activator and uses thereofUNIV RES INST INC AUGUSTA·Filed 2024·Application pending·0 cites
- 2072US2025154256A1Antibodies to programmed cell death protein 1UNIV RES INST INC AUGUSTA·Filed 2025·Application pending·0 cites
- 2172US2021346496A1Cationic lipid vaccine compositions and methods of usePDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 2271US2025136692A1Antibodies to programmed cell death protein 1 that are pd-1 agonistsGEORGIAMUNE INC·Filed 2024·Application pending·0 cites
- 2366US2021196817A1Compositions and Methods for Selectively Modulating TregsUNIV RES INST INC AUGUSTA·Filed 2020·Application pending·0 cites
- 2457US2025051419A1Polypeptide modulatorsGEORGIAMUNE INC·Filed 2022·Application pending·0 cites
- 2557US2016051669A1Compositions and methods for selectively modulating tregsGEORGIA REGENTS UNIVERSITY RES INST INC·Filed 2015·Application pending·0 cites
- 2656US2025074905A1Akt3 modulatorsGEORGIAMUNE INC·Filed 2022·Application pending·0 cites
- 2756US2018153898A1Compositions for modulating pd-1 signal transductionUNIV RES INST INC AUGUSTA·Filed 2017·Application pending·0 cites
- 2856US2023295114A1Akt3 modulatorsGEORGIAMUNE LLC·Filed 2021·Application pending·0 cites
- 2955US2023183226A1Akt3 modulatorsGEORGIAMUNE LLC·Filed 2021·Application pending·0 cites
- 3055US2023219927A1Akt3 modulatorsGEORGIAMUNE LLC·Filed 2021·Application pending·0 cites
- 3155US2020147091A1Compositions for modulating pd-1 signal transductionUNIV RES INST INC AUGUSTA·Filed 2020·Application pending·0 cites
- 3254US2025002511A1Akt3 modulatorsGEORGIAMUNE INC·Filed 2022·Application pending·0 cites
- 3354US2023181563A1Akt3 modulators and methods of use thereofGEORGIAMUNE LLC·Filed 2021·Application pending·0 cites
- 3449US2024228457A1Akt3 modulatorsGEORGIAMUNE INC·Filed 2021·Application pending·0 cites
- 3544US2017216355A1Methods and Compositions for Enhancing T Cell Function and SurvivalAUGUSTA UNIV RES INST INC·Filed 2017·Application pending·0 cites
- 3643US2017368157A1Combination Of Listeria-Based Vaccine With Anti-OX40 Or Anti-GITR AntibodiesADVAXIS INC·Filed 2015·Application pending·0 cites
- 3736US2015297310A1Methods for selecting a treatment for cancerGEORGIA REGENTS RES INST INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mikayel Mkrtichyan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →